Xiaohua Zhu,
Xie, YingYing
Huang, Wenyan
Chen, Zigui
Guo, SuiQun
Article History
Received: 30 April 2021
Accepted: 25 February 2022
First Online: 29 March 2022
Declarations
:
: The use of human ovarian cancer tissue was reviewed and approved by the Ethics Committee of Zhujiang Hospital, Southern Medical University and Shanghai Outdo Biotech company, and performed in accordance with the approved guidelines. Written informed consent was obtained from the ovarian cancer patients.
: Not applicable.
: The authors declare that they have no competing interests.